Mike Polark
Stock Analyst at Wolfe Research
(3.19)
# 957
Out of 4,818 analysts
68
Total ratings
44.19%
Success rate
1.85%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $24.34 | +19.15% | 1 | Mar 31, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $252 → $248 | $148.57 | +66.92% | 6 | Feb 11, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $70.46 | -14.85% | 4 | Jan 16, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $100 → $79 | $102.93 | -23.25% | 7 | Nov 1, 2024 | |
| RMD ResMed | Downgrades: Underperform | $180 | $214.36 | -16.03% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $99.54 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $357.11 | +13.41% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $36.35 | +51.31% | 8 | Aug 28, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $487.93 | +3.09% | 7 | Jul 19, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $246.79 | -18.96% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $129.82 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $133.00 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $67.25 | +79.93% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $16.57 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $10.87 | +129.99% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $158.07 | +4.38% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $98.87 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $83.72 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.93 | +18.94% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $6.05 | +247.11% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $223.96 | +11.63% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.58 | +2,621.52% | 1 | Sep 2, 2020 |
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $24.34
Upside: +19.15%
Inspire Medical Systems
Feb 11, 2025
Maintains: Outperform
Price Target: $252 → $248
Current: $148.57
Upside: +66.92%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $70.46
Upside: -14.85%
iRhythm Technologies
Nov 1, 2024
Maintains: Outperform
Price Target: $100 → $79
Current: $102.93
Upside: -23.25%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $214.36
Upside: -16.03%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $99.54
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $357.11
Upside: +13.41%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $36.35
Upside: +51.31%
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $487.93
Upside: +3.09%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $246.79
Upside: -18.96%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $129.82
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $133.00
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $67.25
Upside: +79.93%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $16.57
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $10.87
Upside: +129.99%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $158.07
Upside: +4.38%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $98.87
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $83.72
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $10.93
Upside: +18.94%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $6.05
Upside: +247.11%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $223.96
Upside: +11.63%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.58
Upside: +2,621.52%